The One-Vigilance® Strategic Roadmap to Corporate Excellence

    The drug safety landscape is changing rapidly. Increasingly complex biopharmaceutical products, growing data volumes, advanced technologies and greater patient involvement are pushing pharmacovigilance teams to rethink traditional approaches to safety monitoring and risk management.

    This white paper introduces QbD Group's One-Vigilance® concept: a unified and centralized approach designed to connect the critical elements of pharmacovigilance and streamline drug safety activities across the product lifecycle. It explores how safety teams can move beyond regulatory compliance and align pharmacovigilance with innovation, business strategy, technology and patient needs.

    You'll also discover how real-world data, digital health technologies and advanced analytics can support more proactive and patient-centric vigilance, and how a strategic approach to sourcing and centralization can help organizations improve efficiency while maintaining global and local compliance.

    Key Takeaways

    • Understand the Changing Drug Safety Landscape. Explore how regulatory change, advanced technologies, growing data volumes, globalization and patient-centric approaches are reshaping pharmacovigilance.

    • Discover the One-Vigilance® Vision. Learn how a unified, centralized approach can connect patients, products and adverse events while bringing greater integration to pharmacovigilance activities.

    • Navigate Safety Across New Biopharmaceutical Products. Understand the specific pharmacovigilance challenges associated with ATMPs, biotech products and precision medicine, and why emerging therapies require increasingly adaptable safety strategies.

    • Put Patients and Real-World Data at the Center. Discover how wearables, digital health solutions and RWD can provide richer insights into patient experiences, support earlier safety signal detection and strengthen proactive risk management.

    • Use Advanced Analytics to Strengthen Vigilance. Explore how AI, machine learning and advanced analytics can help identify safety trends and signals in large datasets, enabling earlier detection and more timely intervention.

    • Turn Pharmacovigilance Into a Strategic Value Driver. Learn how centralization, strategic sourcing and the right balance between internal resources and external expertise can improve efficiency while maintaining patient safety and regulatory compliance.